Trial Profile
Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- 13 Oct 2015 New trial record